参考文献/References:
[1]胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J]. 中国循环杂志,2019,34(3):209-220.
[2] Navickas R,Gal D,Laucevi?ius A,et al. Identifying circulating microRNAs as biomarkers of cardiovascular disease:a systematic review[J]. Cardiovasc Res,2016,111(4):322-337.
[3] Zhou Z,Chen Y,Zhang D,et al. MicroRNA-30-3p suppresses inflammatory factor-induced endothelial cell injury by targeting TCF21[J]. Mediators Inflamm,2019,2019:1342190.
[4] Zhang L,Zhou C,Qin Q,et al. LncRNA LEF1-AS1 regulates the migration and proliferation of vascular smooth muscle cells by targeting miR-544a/PTEN axis[J].J Cell Biochem,2019,120(9):14670-14678.
[5] Wolfs IM,Donners MM,de Winther MP. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation[J]. Thromb Haemost,2011,106(5):763-771.
[6] Yang S,Li J,Chen Y,et al. MicroRNA-216a promotes M1 macrophages polarization and atherosclerosis progression by activating telomerase via the Smad3/NF-kappaB pathway[J]. Biochim Biophys Acta Mol Basis Dis,2019,1865(7):1772-1781.
[7] 武亚琳,梁斌,杨志明. NLRP3/IL-1β途径的促动脉粥样硬化作用及临床应用[J]. 心血管病学进展,2019,40(6):943-946.
[8] Yin Y,Li X,Sha X,et al. Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway[J]. Arterioscler Thromb Vasc Biol,2015,35(4):804-816.
[9] Wu X,Zhang H,Qi W,et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis[J]. Cell Death Dis,2018,9(2):171.
[10] Jiang C,Jiang L,Li Q,et al. Acrolein induces NLRP3 inflammasome-mediated pyroptosis and suppresses migration via ROS-dependent autophagy in vascular endothelial cells[J]. Toxicology,2018,410:26-40.
[11] Chen H,Lu Y,Cao Z,et al. Cadmium induces NLRP3 inflammasome-dependent pyroptosis in vascular endothelial cells[J]. Toxicol Lett,2016,246:7-16.
[12] Pan J,Han L,Guo J,et al. AIM2 accelerates the atherosclerotic plaque progressions in ApoE-/- mice[J]. Biochem Biophys Res Commun,2018,498(3):487-494.
[13] Han Y,Qiu H,Pei X,et al. Low-dose sinapic acid abates the pyroptosis of macrophages by downregulation of lncRNA-MALAT1 in rats with diabetic atherosclerosis[J]. J Cardiovasc Pharmacol,2018,71(2):104-112.
[14] Li X,Zeng L,Cao C,et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy[J]. Exp Cell Res,2017,350(2):327-335.
[15] Jeyabal P,Thandavarayan RA,Joladarashi D,et al. MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1[J]. Biochem Biophys Res Commun,2016,471(4):423-429.
[16] Dong N,Wang Y. MiR-30a regulates S100A12-induced retinal microglial activation and inflammation by targeting NLRP3[J]. Curr Eye Res,2019,44(11):1236-1243.?
[17] Hu Z,Lv X,Chen L,et al. Protective effects of microRNA-22-3p against retinal pigment epithelial inflammatory damage by targeting NLRP3 inflammasome[J]. J Cell Physiol,2019,234(10):18849-18857.
[18] Li P,Zhong X,Li J,et al. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis[J]. Biochem Biophys Res Commun,2018,503(4):2833-2840.
[19] Zhaolin Z,Jiaojiao C,Peng W,et al. OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway[J]. J Cell Physiol,2019,234(5):7475-7491.
[20] Wang J,Wu Q,Yu J,et al. miR-125a-5p inhibits the expression of NLRP3 by targeting CCL4 in human vascular smooth muscle cells treated with ox-LDL[J]. Exp Ther Med,2019,18(3):1645-1652.
[21] Song J,Yang S,Yin R,et al. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL[J]. J Cell Biochem,2019,120(8):13640-13650.
相似文献/References:
[1]李思瑶 钟江华.MicroRNA与心房颤动关系的研究进展[J].心血管病学进展,2020,(1):34.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.010]
LI SiyaoZHONG Jianghua.The Relationship Between MicroRNA and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(5):34.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.010]
[2]谢建华,赵鸿泽,刘剑雄.MicroRNA在心肌梗死后左室重塑和心力衰竭发展中的研究现状[J].心血管病学进展,2020,(3):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
XIE Jianhua,ZHAO Hongze,LIU Jianxiong.MicroRNA in Development of Left Ventricular Remodeling and Heart Failure after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(5):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
[3]谭海鹏 高金峰 李琦玉 王樵梓 张宁 陈婧 黄浙勇.MicroRNA促进心肌细胞再生机制的研究进展[J].心血管病学进展,2020,(7):698.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.007]
TAN Haipeng,GAO Jinfeng,LI Qiyu,et al.Mechanism of MicroRNA Promoting Cardiomyocyte Regeneration[J].Advances in Cardiovascular Diseases,2020,(5):698.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.007]
[4]张依格 常盼 王西辉 王建榜.细胞焦亡在心血管疾病中的作用进展[J].心血管病学进展,2020,(7):724.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.013]
ZHANG Yige,CHANG Pan,WANG Xihui,et al.Role of Pyroptosis in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(5):724.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.013]
[5]朱晓龙侯阳.细胞焦亡的分子机制其在心血管病变中的研究进展[J].心血管病学进展,2020,(8):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
ZHU Xiaolong,HOU Yang.Molecular Mechanism of yroptosis and Its Research Progress in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(5):847.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.016]
[6]韩敏 朱兵 余嘉清 马依彤.程序性细胞死亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(10):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
HAN MinZHU BingYU JiaqingMA Yitong. Programmed Cell Death and Myocardial Ischemic Reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(5):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
[7]冯松林 余皓 吴欣择 李朝阳 施森.MicroRNA在腹主动脉瘤发生和发展中的调控机制[J].心血管病学进展,2020,(11):1168.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
Abdominal Aortic Aneurysm.Regulatory Mechanism of MicroRNA in Occurrence and Development of[J].Advances in Cardiovascular Diseases,2020,(5):1168.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[8]郭双 邢栋 吕勃.程序性坏死、细胞焦亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(12):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
GUO Shuang,XING Dong,LYU Bo.NecroptosisPyroptosis and Myocardial Ischemia-reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(5):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
[9]陈秋宏 王春彬 吴奇.肺动脉高压相关生物标志物的研究新进展[J].心血管病学进展,2021,(11):986.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
CHEN Qiuhong,WANG Chunbin,WU Qi.Pulmonary Hypertension-Related Biomarkers[J].Advances in Cardiovascular Diseases,2021,(5):986.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
[10]李心瑶 陈俊 李灼.脓毒症心肌病的发病机制研究进展[J].心血管病学进展,2024,(1):44.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.012]
LI Xinyao,CHEN Jun,LI Zhuo.Pathogenesis of Septic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2024,(5):44.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.012]